
|Articles|June 26, 2008
HIV drug Aptivus gains new indication approval for kids
Boehringer Ingelheim's Aptivus can now be used to treat HIV-infected pediatric patients.
Advertisement
Pediatric patients between two and 18 years of age who are infected with HIV have a new treatment available to them. It’s Boehringer Ingelheim Pharmaceuticals’
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
3
Individualized Approach Helps When Intensifying GLP-1 Therapy in T2D
4
Meta-Analysis Identifies 5 Risk Factors for Post-COVID-19 Condition
5







































